Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders
Journal of Psychoactive Drugs May 8, 2017 Kelan Thomas, Benjamin Malcolm, Dan Lastra 77 citations
A review of seven clinical trials found that psilocybin-assisted therapy reduced symptoms of anxiety, depression, and substance use, with large effect sizes for improved depression and anxiety. Reductions in alcohol or tobacco use and increased abstinence rates in addiction were less clear due to open-label designs without statistical analysis. The therapy appears promising, but more robust trials are needed for FDA approval.